TransMedics Group, Inc. (TMDX) Profit Margin
TransMedics Group, Inc. (TMDX) net profit margin by fiscal period. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2019-12-31 | -142.12% |
| 2020-12-31 | -111.94% |
| 2021-12-31 | -146.11% |
| 2022-12-31 | -38.77% |
| 2023-12-31 | -10.36% |
| 2024-12-31 | 8.03% |
| 2025-12-31 | 31.43% |
How TMDX compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| AMPH | Amphastar Pharmaceuticals Inc. | 13.63% |
| IQV | IQVIA Holdings Inc. | 8.34% |
| EBS | Emergent BioSolutions Inc. | 7.08% |
| ABBV | AbbVie Inc. | 6.91% |
| ENSG | The Ensign Group Inc. | 6.80% |
These are five companies in the same sector as TMDX with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get TransMedics Group, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("TMDX", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | TMDX | $88.35 | -0.26% | 0.26M |
| 3 | ||||
| 4 | ||||
| 5 |